Financials

News Ideas Discussions Technicals Forecast Seasonals

VX1 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of VERTEX PHARMAC. DL-,01

Total assets of VX1 for Q3 24 is 19.97 B EUR, 6.28% more than the previous Q2 24. And total liabilities increased by 18.68% in Q3 24 to 5.94 B EUR.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—